Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Anbing He"'
Autor:
Huilin Xu, Dedong Cao, Dingjie Zhou, Nan Zhao, Xixian Tang, Vishalkumar G. Shelat, Hrishikesh Samant, Sanjaya K. Satapathy, Francisco Tustumi, Giuseppe Aprile, Anbing He, Ximing Xu, Wei Ge
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background The use of regorafenib in the treatment of hepatocellular carcinoma (HCC) is widespread. Albumin-Bilirubin (ALBI) has been shown to be a potential prognostic marker for regorafenib treatment, but its prognostic value remains contr
Externí odkaz:
https://doaj.org/article/9b934b28623f4f7d883bcbbd599a3cc3
Publikováno v:
Chemical Biology & Drug Design; Jan2024, Vol. 103 Issue 1, p1-11, 11p
Publikováno v:
Tumori Journal. 109:203-214
Background: Anlotinib is one of the tyrosine kinase inhibitors that exhibits promising anti-tumor effect in several cancers. However, the efficacy and safety of anlotinib in pre-treated small cell lung cancer (SCLC) is not well determined. Herein, we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72f300ce658825d41556ba88efff78e5
https://doi.org/10.1177/03008916221082704
https://doi.org/10.1177/03008916221082704
Publikováno v:
International Journal of General Medicine
Xiulan Peng,1,* Yali Huang,1,* Haifeng Fu,2,* Zhi Zhang,3 Anbing He,1 Renfeng Luo4 1Department of Oncology, The Second Affiliated Hospital of Jianghan University, Wuhan, Hubei, Peopleâs Republic of China; 2Department of Hepatopancrea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::853b60cfdc8d811394c6362d0ddcdfa9
https://doi.org/10.2147/ijgm.s337822
https://doi.org/10.2147/ijgm.s337822
Background We attempted to evaluate the clinical and prognostic significance of APOA1 mRNA and protein in kidney renal clear cell carcinoma (KIRC). Methods Clinical data along with RNA-sequencing data were downloaded from UCSC Xena. The Human Protein
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::59286b55075b335f4568a5801966896c
https://doi.org/10.21203/rs.3.rs-1380075/v1
https://doi.org/10.21203/rs.3.rs-1380075/v1
Publikováno v:
Medical Science Monitor. 27
BACKGROUND The results of previous studies that evaluated the association between pretreatment blood platelet-to-lymphocyte ratio (PLR) and clinical outcomes and chemosensitivity in patients with advanced gastric cancer are inconsistent. Therefore, t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04e1c88131daa9984c9fbbb849cbfc92
https://doi.org/10.12659/msm.933449
https://doi.org/10.12659/msm.933449
Publikováno v:
Disease markers. 2022
Objective. This study was aimed at exploring the prognostic and clinicopathological roles of aspartate aminotransferase-to-lymphocyte ratio index (ALRI) in patients with hepatocellular carcinoma via a meta-analysis. Methods. The PubMed, Embase, Cochr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::930147cdced05bca48e85cd32e698f5b
https://pubmed.ncbi.nlm.nih.gov/35186165
https://pubmed.ncbi.nlm.nih.gov/35186165
Autor:
Xiulan, Peng, Renfeng, Luo, Jingtao, Li, Anbing, He, Xia, Wang, Huan, Wan, Yahong, Cai, Weiguo, Dong, Jun, Lin
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 25(4)
Liver cancer or hepatocellular carcinoma (HCC) is considered as one of the most frequent malignancies with significantly high morbidity and mortality across the globe. MicroRNAs (miRs) are regarded as important regulators of liver cancer formation an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::893c478834f332588e9fab5fe85363c1
https://pubmed.ncbi.nlm.nih.gov/33099931
https://pubmed.ncbi.nlm.nih.gov/33099931
Autor:
Xiulan, Peng, Changli, Ruan, Changjiang, Lei, Anbing, He, Xia, Wang, Renfeng, Luo, Yahong, Cai, Weiguo, Dong, Jun, Lin
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 25(3)
Gastric carcinoma is the fourth leading cause of cancer-related morbidity throughout the globe. There are limited clinical therapies for gastric cancer due to lack of effective drugs and ambiguity in molecular mechanisms. As such there is a pressing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::24dca32a4ff957d87264bd97507588af
https://pubmed.ncbi.nlm.nih.gov/32862591
https://pubmed.ncbi.nlm.nih.gov/32862591
Publikováno v:
Medical Science Monitor; 1/31/2022, Vol. 28, p1-14, 14p